Related Experiment Video
Updated: Jul 16, 2026
10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
Systemic anticancer therapy in gynecological cancer patients with renal dysfunction
1Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77230, USA.
Summary
Patients with gynecological cancer and chronic kidney disease require careful systemic anticancer treatment. This review details drug nephrotoxicity, pharmacokinetics, and dose adjustments for chemotherapy agents to prevent toxicity.
Area of Science:
- Oncology
- Nephrology
- Clinical Pharmacology
Background:
- Chronic kidney disease (CKD) is prevalent in gynecological cancer patients.
- Altered pharmacokinetics in CKD complicates systemic anticancer treatment.
- Renal impairment can increase drug exposure and toxicity, necessitating dose adjustments.
Purpose of the Study:
- To review nephrotoxicity and pharmacokinetic data for systemic anticancer agents used in gynecological cancers.
- To provide dose adjustment guidelines for medications in patients with impaired renal function.
- To summarize formulas for estimating creatinine clearance.
Main Methods:
- Literature review of nephrotoxicity and pharmacokinetic data for relevant anticancer drugs.
- Identification of drugs requiring dose adjustment versus those that do not.
- Review of creatinine clearance estimation formulas (Cockcroft-Gault, Chatelut, Jelliffe, Wright, MDRD).
Main Results:
- 17 medications identified as requiring dose adjustment (e.g., cisplatin, carboplatin, cyclophosphamide).
- 27 medications identified as not requiring dose adjustment (e.g., paclitaxel, gemcitabine, trastuzumab).
- Common creatinine clearance estimation formulas were reviewed.
Conclusions:
- Systemic anticancer therapy in gynecological cancer patients with CKD demands careful consideration of drug pharmacokinetics and renal function.
- Appropriate dose adjustments are crucial to mitigate toxicity and ensure treatment efficacy.
- Utilizing validated formulas for creatinine clearance estimation aids in safe medication management.
Related Concept Videos
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
01:18Chronic Kidney Disease IV: Nursing Management
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
01:28Renal Drug Excretion: Tubular Secretion
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
01:15Renal Drug Excretion: Overview
As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules out...
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules out...
01:06Renal Drug Clearance: Overview
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...